KYMR · CIK 0001815442 · operating
Kymera Therapeutics, Inc. (KYMR) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $7.2 billion, Kymera Therapeutics, Inc. is a mid-cap company. The stock currently trades at $90.10, down 1.37% today, with a 52-week range of $19.45–$103.00.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-3.69 | $-3.69 | -23.8% | |
| 2024 | $-2.98 | $-2.98 | -18.3% | |
| 2023 | $-2.52 | $-2.52 | +12.2% | |
| 2022 | $-2.87 | $-2.87 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-26 | 0001193125-26-073395 | SEC ↗ |
| 2024-12-31 | 2025-02-27 | 0000950170-25-028355 | SEC ↗ |
| 2023-12-31 | 2024-02-22 | 0000950170-24-018414 | SEC ↗ |
| 2022-12-31 | 2023-02-23 | 0000950170-23-003935 | SEC ↗ |
| 2021-12-31 | 2022-02-24 | 0000950170-22-001860 | SEC ↗ |
| 2020-12-31 | 2021-03-11 | 0001564590-21-012240 | SEC ↗ |